Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.
Drugmaker GlaxoSmithKline entered into a four-year collaboration with 23andMe to use human genetics to guide drug development, investing $300M in the direct-to-consumer genetic testing company to fund ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The rival bid from the 23andMe ...
July 10 (Reuters) - A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne Wojcicki pending the outcome of a legal challenge by ...
A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Justin Sullivan/Getty; Michael Nagle/Bloomberg via Getty Genetics company 23andMe is expected to ...
The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. How to conduct your own portfolio makeover ...
Remember 23andMe? The company that gave customers saliva-based DNA testing kits to learn about their ancestry? Founded in 2006, the company also conducted health research and drug development. But it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback